Control of virus-induced lymphoproliferation: Epstein-Barr virus- induced lymphoproliferation and host immunity

Molecular Medicine Today

Volumn 3, Issue 1, 1997, Pages 24-30

  Rooney, C M ^a   Smith, C A ^a   Heslop, H E ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL TRANSFORMATION; CONTROL SYSTEM; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; REVIEW; VIRUS EXPRESSION; VIRUS INDUCTION; VIRUS INFECTION;

EID: 0031426570     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(96)10054-X     Document Type: Review

References (44)

1. Straus S.E. Cohen J.I. Tosato G. Meier J. Epstein-Barr virus infections: biology, pathogenesis and management Ann. Intern. Med. 118 1992 45 58
2. Klein G. Epstein-Barr virus strategy in normal and neoplastic B cells Cell 77 1994 791 793
3. Rickinson A.B. EBV infection and EBV-associated tumors Minson A.C. Neil J.C. McRae M.A. Viruses and Cancer 1994 Cambridge University Press 81 100
4. Cohen K.I. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency Proc. Natl. Acad. Sci. U. S. A. 86 1991 9558 9561
5. Hummell M. Kieff E. Epstein-Barr virus RNA VIII. Viral RNA in permissively infected B95-8 cells J. Virol. 43 1982 262 272
6. de Waal Malefyt R. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression J. Exp. Med. 174 1991 915 924
7. Tierney R.J. Steven N. Young L.S. Rickinson A.B. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state J. Virol. 68 1994 7374 7385
8. Yao Q.Y. Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers Int. J. Cancer 43 1989 67 71
9. Murray R.J. J. Exp. Med. 176 1992 157 168
10. Brooks L.A. Lear A.L. Young L.S. Rickinson A.B. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies J. Virol. 67 1993 3182 3190
11. Wilson J.B. Levine AJ. The oncogenic potential of Epstein-Barr virus nucear antigen 1 in transgenic mice Curr. Top. Microbiol. Immunol. 182 1992 375 384
12. Rooney CM. Rowe M. Wallace L.E. Rickinson A.B. Epstein-Barr virus positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance Nature 317 1985 629 631
13. Gregory C.D. Murray R.J. Edwards C.F. Rickinson A.B. Down regulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr vims-positive Burkitt's lymphoma underlies tumour cell escape from virusspecific T cell surveillance J. Exp. Med. 167 1986 1811 1824
14. Stuber G. HLA-A201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1 Int. Immunol. 7 1995 653 663
15. Levitskaya J. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1 Nature 375 1995 685 688
16. Khanna R. Burrows S.R. Argaat V. Moss D.J. Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line Int. Immunol. 6 1994 639 645
17. Masucci M.G. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vivo reconstitution of sensitivity to EBV-specific cytotoxic T cells Int. Immunol. 4 1992 1283 1292
18. Frisan T. Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease Blood 86 1995 1493 1501
19. Wang F. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 J. Virol. 64 1990 2309 2318
20. Khanna R. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development J. Exp. Med. 176 1992 169 176
21. Allday M.J. Kunda D. Finerty S. Griffin B.E. CpG methylation of viral DNA in EBV-associated tumours Int. J. Cancer 45 1990 1125 1130
22. Masucci M.G. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line Rael J. Virol. 63 1989 3135 3141
23. Razzouk B.I. Epstein-Barr virus DNA recombination and loss in sporadic Burkitt's lymphoma J. Inf. Dis. 3 1996 529 535
24. Patte C. Therapy of Burkitt and other B-cell acute lymphoblastic leukemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults Ballière's Clin. Haematol. 7 1994 339 348
25. Haluska F.G. Brufsky A.M. Canellos G.P. The cellular biology of the Reed-Sternberg cell Blood 84 1994 1005 1019
26. Weiss L.M. Movahed L.A. Warnke R.A. Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease New Engl J. Med. 320 1989 502 506
27. Pallesen G. Hamilton-Dutoit S.J. Rowe M. Young L.S. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease Lancet 337 1991 320 322
28. Filipovich A.H. Lymphoproliferative disorders and other tumors complicating immunodeficiencies Immunodeficiency 5 1992 91 112
29. Ho M. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children Transplantation 45 1988 719 727
30. Shapiro R.S. Treatment of B cell lymphoproliferative disorders with interferon α and intravenous γ-globulin New Engl. J. Med. 318 1988 1334 1337
31. Fischer A. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliverative syndrome following bone marrow and organ transplantation New Engl. J. Med. 324 1991 1451 1456
32. Leblond V. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center J. Clin. Oncol. 13 1996 961 968
33. Heslop H.E. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virusspecific T lymphocytes s Nat. Med. 2 1996 551 555
34. Lucas K. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation Blood 87 1996 2594 2603
35. Papadopoulos E.B. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation New Engl. J. Med. 330 1994 1185 1191
36. Heslop H.E. Brenner M.K. Rooney C.M. Donor T cells to treat EBV-associated lymphoma New Engl. J. Med. 331 1994 679 680
37. Walter E.A. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor New. Engl J. Med. 333 1995 1038 1044
38. Bourgault I. Gomez A. Gomard E. Levy J.P. Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes Clin. Exp. Immunol. 84 1991 501 507
39. Heslop H.E. Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts Hum. Gene Ther. 5 1994 381 397
40. Smith C.A. Production of genetically modified EBV-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease J. Hematother. 4 1995 73 79
41. Rooney C.M. Early identification of Epstein-Barr virus-associated post-transplant lymphoproliferative disease Br. J. Haematol. 89 1995 98 103
42. Rooney C.M. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation Lancet 345 1995 9 13
43. Boyle M.J. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma Blood 78 1991 3004 3011
44. Yates J.L. Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells Nature 313 1985 812 815